Mucocutaneous manifestations of Epstein-Barr virus infection

dc.contributor.authorMendoza, Natalia
dc.contributor.authorDiamantis, Melissa
dc.contributor.authorArora, Anita
dc.contributor.authorBartlett, Brenda
dc.contributor.authorGewirtzman, Aron
dc.contributor.authorTremaine, Anne-Marie
dc.contributor.authorTyring, Stephen
dc.date.accessioned2020-11-11T20:11:59Z
dc.date.available2020-11-11T20:11:59Z
dc.date.issued2008
dc.description.abstractenglishThis review focuses on Epstein-Barr virus (EBV) infection, diagnosis, and current treatment, with emphasis on EBV-associated mucocutaneous manifestations in primary infections, acute EBV-associated syndromes, chronic infections, lymphoproliferative disorders, and lymphomas. In primary infection, EBV infects B cells and can cause mucocutaneous manifestations in infectious mononucleosis or acute EBV-associated syndromes such as Gianotti-Crosti syndrome and hemophagocytic syndrome. EBV then persists in the majority of humans generally without causing disease. In some cases, however, latent EBV infection may result in diseases such as hydroa vacciniforme, hypersensitivity to mosquito bites, and lymphoproliferative disorders such as plasmablastic lymphoma, oral hairy leukoplakia, and post-transplant lymphoproliferative disorders, particularly in immunocompromised patients. Latent EBV infection has also been implicated in a variety of malignant conditions such as Burkitt lymphoma, Hodgkin lymphoma, nasopharyngeal carcinoma, and Kikuchi histocytic necrotizing lymphadenitis. Since the immune system is critical in preventing the progression of EBV disease, the immunologic status of the patient plays a crucial role in the subsequent development of pathologies.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.2165/00128071-200809050-00003
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn1179-1888
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlhttps://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/4677
dc.language.isoeng
dc.publisherSpringer Linkspa
dc.publisher.journalAmerican Journal of Clinical Dermatologyspa
dc.relation.ispartofseriesAmerican Journal of Clinical Dermatology, 1179-1888, Vol. 9, Nro. 5, 2008 p. 295-305spa
dc.relation.urihttps://link.springer.com/article/10.2165/00128071-200809050-00003
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abierto
dc.rights.creativecommons2008
dc.rights.localAcceso abiertospa
dc.subject.decsSíndrome mucocutáneo linfonodularspa
dc.subject.decsEpstein-Barrspa
dc.subject.decsInfeccionesspa
dc.titleMucocutaneous manifestations of Epstein-Barr virus infectionspa
dc.title.translatedMucocutaneous manifestations of Epstein-Barr virus infectionspa
dc.type.coarhttps://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículo de revista

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Mendoza_Natalia_2008.pdf
Tamaño:
2.16 MB
Formato:
Adobe Portable Document Format
Descripción:
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones